Specific Targeting of Tuberculosis Rifampicin-Tolerant Populations

Javid, Zhu, and colleagues of Tsinghua University in China have developed a strategy to isolate phenotypically-resistant mycobacteria. They will therefore be able to identify small molecules that are specific for this subpopulation as opposed to the bulk tuberculosis population, which may in turn identify pathways to accelerate TB therapy.